According to a regulatory filing, Sun Pharma has acquired 26.09 per cent stake in Agatsa Software to boost digital diagnostics.
It has also bagged a 27.39 per cent stake in Remedio Innovative Solutions, for eye disease detection.
Sun Pharma forays into health tech with investments in Agatsa Software and Remedio
The acquisitions will boost the pharma giant's investments in digital healthcare.
RECENT STORIES
Exciting Investment Opportunities Are Available, In The Capital Market
Coromandel International Q4 Profit Falls 33% To ₹164 Cr On Lower Income
PM SVANidhi: Centre Paid ₹147.82 Crore In Interest Subsidy On Loans
'It Levels The Playing Field': After Old Video, Nikhil Kamath's Article Supporting Inheritance Tax...
Rupee On The Rise: Expert Forecasts Appreciation To ₹82-82.50 In FY25
